National Cancer Institute; Notice of Closed Meetings, 3443 [2016-01068]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 13 / Thursday, January 21, 2016 / Notices
selected candidate is involved in any
activity that may pose a potential
conflict with the official duties to be
performed as a member of SACHRP.
Dated: January 14, 2016.
Julia Gorey,
Executive Director, Secretary’s Advisory
Committee on Human Research Protections.
[FR Doc. 2016–01049 Filed 1–20–16; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
asabaliauskas on DSK9F6TC42PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Quantitative Imaging for Evaluation of
Response to Cancer Therapies (U01).
Date: February 25, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
5W030, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W266, Bethesda, MD 20892–9750,
240–276–6385, lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Technologies for Cancer-Relevant
Biospecimen Science.
Date: March 2, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2W904, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division Of Extramural Activities, National
VerDate Sep<11>2014
18:26 Jan 20, 2016
Jkt 238001
Cancer Institute, 9609 Medical Center Drive,
Room 7W238, Bethesda, Md 20892–9750,
240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus SEP–6.
Date: March 7–8, 2016.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Dona Love, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W236, Rockville, MD 20850,
240–276–5264, donalove@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Outstanding Investigator Award I.
Date: March 22–24, 2016.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Michael B. Small, Ph.D.,
Chief, Program and Review Extramural Staff
Training Office, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W412,
Rockville, MD 20850, 240–276–6438,
smallm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Outstanding Investigator Award II.
Date: March 22–24, 2016.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Shamala K. Srinivas,
Ph.D., Scientific Review Officer, Office of
Referral, Review, and Program Coordination,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W530, Bethesda, MD 20892–
8328, 240–276–6442, ss537t@nih.gov,
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
3443
Dated: January 14, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–01068 Filed 1–20–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group—Cellular
Aspects of Diabetes and Obesity Study
Section.
Date: February 9–10, 2016.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Antonello Pileggi, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 6166,
Bethesda, MD 20892–7892, (301) 402–6297,
pileggia@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group—Macromolecular Structure
and Function A Study Section.
Date: February 11–12, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Serrano Hotel, 405 Taylor Street,
San Francisco, CA 94102.
Contact Person: Nitsa Rosenzweig, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7760, Bethesda, MD 20892, (301) 404–
7419, rosenzweign@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review
Group—Community Influences on Health
Behavior Study Section.
Date: February 11–12, 2016.
Time: 8:00 a.m. to 5:00 p.m.
E:\FR\FM\21JAN1.SGM
21JAN1
]]>Agencies
[Federal Register Volume 81, Number 13 (Thursday, January 21, 2016)]
[Notices]
[Page 3443]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01068]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Quantitative Imaging for Evaluation of Response to Cancer
Therapies (U01).
Date: February 25, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 5W030, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W266, Bethesda, MD 20892-9750, 240-276-6385,
lovingeg@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Technologies for Cancer-Relevant Biospecimen Science.
Date: March 2, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2W904, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division Of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W238, Bethesda, Md 20892-9750, 240-276-6371,
decluej@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus SEP-6.
Date: March 7-8, 2016.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Dona Love, Ph.D., Scientific Review Officer,
Special Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, 7W236, Rockville,
MD 20850, 240-276-5264, donalove@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Outstanding Investigator Award I.
Date: March 22-24, 2016.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Michael B. Small, Ph.D., Chief, Program and
Review Extramural Staff Training Office, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W412, Rockville, MD 20850, 240-276-6438,
smallm@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Outstanding Investigator Award II.
Date: March 22-24, 2016.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Shamala K. Srinivas, Ph.D., Scientific Review
Officer, Office of Referral, Review, and Program Coordination,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W530, Bethesda, MD 20892-8328, 240-
276-6442, ss537t@nih.gov,
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 14, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-01068 Filed 1-20-16; 8:45 am]
BILLING CODE 4140-01-P
